Midbrain dopaminergic neurons in the mouse that contain calbindin-D(28k) exhibit reduced vulnerability to MPTP-induced neurodegeneration

Neurodegeneration

Volumn 5, Issue 4, 1996, Pages 313-318

  Liang, Chang Lin ^a   Sinton, Christopher M ^a   Sonsalla, Patricia K ^b   German, Dwight C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Calbindin D(28k) double labelling immunocytochemistry; Midbrain dopaminegic neurons; Mouse; MPTP

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CALBINDIN; CALCIUM BINDING PROTEIN; NEUROTOXIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; IMAGING SYSTEM; IMMUNOCYTOCHEMISTRY; MALE; MESENCEPHALON; MONKEY; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; VENTRAL TEGMENTUM;

EID: 0030513477     PISSN: 10558330     EISSN: None     Source Type: Journal    
DOI: 10.1006/neur.1996.0042     Document Type: Article

References (29)

1. Aral N, Misugi K, Goshima Y (1990) Evaluation of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57 black mouse model for Parkinsonism. Brain Res 515:57-63
2. Baimbridge KG, Celio MR, Rogers JH (1992) Calcium-binding proteins in the nervous system. TINS 15:303-308
3. 28k in transgenic mice and effects on working memory: a putative model of Alzheimer's disease. Neurosci Abstr 20:170
4. Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ (1983) A primate model of Parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 80:4546-4550
5. Christakos S, Gabrielides C, Rhoten WB (1989) Vitamin D-dependent calcium binding proteins: chemistry, distribution, functional considerations, and molecular biology. Endo Rev 10:3-26
6. Elsworth JD, Deutch AY, Redmond Jr DE, Sladek Jr. JR, Roth RH (1987) Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF. Brain Res 415:293-299
7. German DC, Dubach M, Askari S, Speciale SG, Bowden DM (1988) 1-methyl-4-phenyl-1,2,3,6-tretrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost? Neurosci 24:161-174
8. German DC, Manaye K, Smith WK, Woodward DJ, Saper CB (1989) Midbrain dopaminergic cell loss in Parkinson's Disease: computer visualization. Ann Neurol 26:507-514
9. 28k-containing cells. Ann New York Acad Sci 648:42-62
10. German DC, Nelson EL, Liang C-L, Speciale SG, Sinton CM, Sonsalla PK (1996a) The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse. Neurodegeneration 5:299-312
11. 28k in nerve cell nuclei. Neurosci 5: in press
12. Heikkila RE, Hess A, Duvoisin RC (1984) Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Science 224:1451-1453
13. 28k-like immunoreactivity in catecholaminergic cell groups of the human midbrain: normal distribution and distribution in Parkinson's disease. Neurodegeneration 1:83-93
14. 28k-containing neurons in animal models of neurodegeneration: possible protection from excitotoxicity. Mol Brain Res 13:251-261
15. 28k: a potential neuroprotective protein. Neurodegeneration 3:1-20
16. Kass GEN, Wright JM, Nicotera P, Orrenius S (1988) The mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity: role or intracellular calcium. Arch Biochem Biophys 260:789-797
17. Lavoie B, Parent A (1991) Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys. NeuroRep 2:601-604
18. 28k and calretinin. Neurosci in press
19. Muthane U, Ramsay KA, Jiang H, Jackson-Lewis V, Donaldson D, Fernando S, Ferreira M, Przedborski S (1994) Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine inC57/b1 and CD-1 mice. Exp Neurol 126:195-204
20. 28k levels in mouse midbrain dopaminergic neurons. Mol Brain Res 36:329-336
21. + and mitochondrial function. Life Sci 40:721-729
22. 28k with tyrosine hydroxylase. Brain Res 587:203-210
23. Sanghera MK, Manaye KF, Liang C-L, Iacopino AM, Bannon MJ, German DC (1994) Low dopamine transporter mRNA levels in midbrain regions containing calbindin. NeuroReport 5:1641-1644
24. 28k. Neurosci Abstr 21:1380
25. Sonsalla PK, Heikkila RE (1986) The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice. Eur J Pharmacol 129:339-345
26. Sundstrom E, Stromberg I, Tsutsumi T, Olson L, Jonsson G (1987) Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons m C57BL/6 mice: comparison with three other strains of mice. Brain Res 405:26-38
27. Varastet M, Riche D, Maziere M, Nantraye P (1994) Chronic MPTP treatment reproduces in baboons the differential vulnerability of mesencephalic dopaminergic neurons observed in Parkinson's Disease. Neurosci 63:47-56
28. Wessendorf MW, Elde RP (1985) Characterization of an immunofluorescence technique for the demonstration of coexisting neurotransmitters within nerve fibers and terminals. J Histochem Cytochem 33:984-994
29. 28k. Brain Res 526:303-307